| | A vaccine scandal in China, which has prompted angry reactions from leaders and citizens fed up with safety scares in the country, is sending ripples across the local drug market and threatening Chinese ambitions to play a larger global role. | |
| (Reuters Health) - Cigarette use decreased among young women - including pregnant women - during the past decade in the U.S., according to a new study. But, researchers found, use of marijuana blunts rose. | |
| Life sciences company Bayer AG said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device that made the business no longer sustainable. | |
| (Reuters Health) - To help more patients survive cardiac arrest, traditional CPR training needs an overhaul with more chances for practice - and instructions on social and digital platforms might help lessons stick, some doctors argue. | |
| (Reuters Health) - A screening test for colon cancer that looks for "invisible" blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests. | |
| A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe. | |
| European drugmakers Roche, Bayer and Merck KGaA became the latest companies to freeze prices in the United States for the rest of 2018 following criticism by President Donald Trump over the cost of medicine. | |
| Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation. | |
| (Reuters Health) - A virtual reality program may work at least as well as one-on-one therapy to help people overcome a fear of heights, a UK study suggests. | |
| Honduras has appealed against a WTO ruling won last month by Australia on its "plain" packaging requirements for tobacco, a WTO spokesman said on Friday. | |
| Drug regulators across Europe are hiring extra staff and increasing their workload as the role of British experts in the EU-wide system of medicines supervision winds down ahead of Brexit. | |
|
| |